Neonatal abstinence syndrome: Historical perspective, current focus, future directions
- PMID: 26232620
- DOI: 10.1016/j.ypmed.2015.07.017
Neonatal abstinence syndrome: Historical perspective, current focus, future directions
Abstract
Background: Neonatal abstinence syndrome (NAS) occurs following prenatal opioid exposure. It is characterized by signs and symptoms indicating central nervous system hyperirritability and autonomic nervous system, gastrointestinal tract, and respiratory system dysfunction.
Objective: This article: (1) briefly reviews NAS history, including initial identification, assessment, and treatment efforts; (2) summarizes the current status of and current issues surrounding recent NAS assessment and treatment, and (3) details future directions in NAS conceptualization, measurement, and treatment.
Results: Mortality rate estimates in neonates treated for NAS exceeded 33%, and surpassed 90% for un-treated infants during the late-1800s until the mid-1900s. The focus of both assessment and treatment over the past 50years is predominantly due to two forces. First, methadone pharmacotherapy for "heroin addiction" led to women in methadone maintenance programs who were, or became pregnant. The second was defining NAS and developing a measure of neonatal withdrawal, the Neonatal Abstinence Scoring System (NASS). Various NAS treatment protocols were based on the NASS as well as other NAS measures.
Conclusions: Future research must focus on psychometrically sound screening and assessment measures of neonatal opioid withdrawal for premature, term and older infants, measuring and treating possible withdrawal from non-opioids, particularly benzodiazepines, integrated non-pharmacological treatment of NAS, weight-based versus symptom-based treatment of NAS, and second-line treatment for NAS.
Keywords: Neonatal abstinence syndrome; Neonatal opioid withdrawal; Opioid use disorder.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.Contemp Clin Trials. 2014 Sep;39(1):158-65. doi: 10.1016/j.cct.2014.08.009. Epub 2014 Aug 23. Contemp Clin Trials. 2014. PMID: 25183042 Clinical Trial.
-
Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.J Addict Med. 2019 Mar/Apr;13(2):90-92. doi: 10.1097/ADM.0000000000000463. J Addict Med. 2019. PMID: 30334926
-
Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.Am J Addict. 2016 Aug;25(5):370-3. doi: 10.1111/ajad.12388. Epub 2016 Jun 11. Am J Addict. 2016. PMID: 27287965 Clinical Trial.
-
Opioid neonatal abstinence syndrome: controversies and implications for practice.Curr Drug Abuse Rev. 2014;7(1):44-58. doi: 10.2174/1874473707666141015215141. Curr Drug Abuse Rev. 2014. PMID: 25323126 Review.
-
Breastfeeding promotion for management of neonatal abstinence syndrome.J Obstet Gynecol Neonatal Nurs. 2013 Sep-Oct;42(5):517-26. doi: 10.1111/1552-6909.12242. Epub 2013 Sep 4. J Obstet Gynecol Neonatal Nurs. 2013. PMID: 24020477 Review.
Cited by
-
Editorial: 2nd Special Issue on behavior change, health, and health disparities.Prev Med. 2015 Nov;80:1-4. doi: 10.1016/j.ypmed.2015.07.020. Epub 2015 Aug 6. Prev Med. 2015. PMID: 26257372 Free PMC article.
-
Analysis of the factors that influence the Finnegan Neonatal Abstinence Scoring System.J Perinatol. 2017 Jul;37(7):814-817. doi: 10.1038/jp.2017.40. Epub 2017 Apr 6. J Perinatol. 2017. PMID: 28383539
-
Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay.Front Pediatr. 2017 Oct 10;5:216. doi: 10.3389/fped.2017.00216. eCollection 2017. Front Pediatr. 2017. PMID: 29067285 Free PMC article.
-
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Drug Saf. 2016 Oct;39(10):903-24. doi: 10.1007/s40264-016-0435-8. Drug Saf. 2016. PMID: 27289228 Review.
-
Examining Stressors and Available Parenting Resources for Opioid-Using Mothers: Qualitative Findings from an Inpatient Substance Use Treatment Program.Community Ment Health J. 2020 Apr;56(3):426-434. doi: 10.1007/s10597-019-00478-6. Epub 2019 Oct 19. Community Ment Health J. 2020. PMID: 31630288 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous